Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?

TheMotleyFool

0 0

Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?: https://g.foolcdn.com/editorial/images/756714/scientist-in-lab-young-african-american-female.jpg

It's rare for a prescription drug to become part of the cultural landscape. However, that's exactly what has happened with Ozempic. Hollywood celebrities and social media have put the GLP-1 agonist in the spotlight.

Novo Nordisk (NYSE: NVO) has no complaints. Thanks largely to the tremendous success of Ozempic and its sibling Wegovy, shares of the Danish biopharmaceutical company have soared.

However, another drugmaker hopes to push Ozempic and Wegovy to the side. And its share price has skyrocketed, too. Is Eli Lilly (NYSE: LLY) a better stock to buy and hold over the next 10 years than Novo Nordisk?

Source Fool.com

Like: 0

LLY

Share